Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

GFAP antibody mediated autoimmune meningo-encephalomyelitis - first reported fatal outcome in a healthy young patient
Multiple Sclerosis
P5 - (-)
389
Authors/Disclosures
Raquel Fonseca, MD (Brigham and Women's Hospital)
PRESENTER
No disclosure on file
Sami Bajwa, MD (Kaiser Permanente) No disclosure on file
Anthony P. Geraci, MD, FAAN (Access Telecare) Dr. Geraci has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Geraci has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Geraci has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Geraci has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Geraci has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Geraci has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Geraci has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion.
Fred A. Lado, MD (Neuroscience Institute of Northwell Health) Dr. Lado has a non-compensated relationship as a Board Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Lado has a non-compensated relationship as a Officer with National Association of Epilepsy Centers that is relevant to AAN interests or activities.